Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › LA › BATON ROUGE › LOUISIANA DEPARTMENT OF HEALTH - OFFICE OF PUBLIC HEALTH

LOUISIANA DEPARTMENT OF HEALTH - OFFICE OF PUBLIC HEALTH

NPI: 1942221098 · BATON ROUGE, LA 70802 · Clinical Medical Laboratory · NPI assigned 07/22/2006

$37.92M
Total Medicaid Paid
2,469,943
Total Claims
1,976,946
Beneficiaries
50
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialCROTWELL, DOROTHY (PROGRAM MANAGER)
NPI Enumeration Date07/22/2006

Related Entities

Other providers sharing the same authorized official: CROTWELL, DOROTHY

ProviderCityStateTotal Paid
LOUISIANA DEPARTMENT OF HEALTH - OFFICE OF PUBLIC HEALTH NEW ORLEANS LA $3.67M
LOUISIANA DEPARTMENT OF HEALTH - OFFICE OF PUBLIC HEALTH BATON ROUGE LA $2.66M
LOUISIANA DEPARTMENT OF HEALTH - OFFICE OF PUBLIC HEALTH NEW ORLEANS LA $2.55M
LOUISIANA DEPARTMENT OF HEALTH - OFFICE OF PUBLIC HEALTH NEW ORLEANS LA $1.51M
LOUISIANA DEPARTMENT OF HEALTH - OFFICE OF PUBLIC HEALTH BATON ROUGE LA $838K
LOUISIANA DEPARTMENT OF HEALTH - OFFICE OF PUBLIC HEALTH NEW ORLEANS LA $594K
OFFICE OF PUBLIC HEALTH -GENETICS DISEASES PROGRAM NEW ORLEANS LA $44K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 435,820 $5.56M
2019 381,106 $5.32M
2020 390,644 $6.23M
2021 324,037 $5.62M
2022 354,564 $4.86M
2023 349,597 $6.04M
2024 234,175 $4.29M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 117,727 94,288 $3.79M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 117,587 94,214 $3.78M
82775 223,757 181,108 $3.66M
83789 223,065 180,697 $3.46M
84143 190,091 153,491 $3.44M
83021 223,239 181,116 $3.23M
82261 223,565 181,113 $3.12M
84443 Thyroid stimulating hormone (TSH) 226,129 181,134 $2.92M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 36,433 19,561 $2.60M
83516 223,648 181,117 $2.00M
81479 Unlisted molecular pathology procedure 164,806 133,639 $1.49M
84437 223,667 181,129 $1.12M
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 3,801 3,309 $692K
83498 38,765 27,604 $623K
86318 47,391 38,812 $454K
86703 47,676 40,660 $387K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 20,366 7,635 $292K
81025 35,436 30,507 $185K
83020 13,100 10,913 $135K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 4,318 3,762 $117K
86481 1,768 1,395 $74K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,931 1,774 $69K
86780 5,356 4,920 $57K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,158 926 $36K
87210 10,532 8,320 $32K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1,849 1,491 $31K
86803 2,284 1,848 $24K
86592 4,053 3,436 $13K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 315 305 $12K
87116 1,410 739 $9K
86593 2,312 1,960 $8K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 5,233 3,862 $7K
81002 3,274 2,789 $7K
84450 2,207 1,547 $6K
85018 3,003 2,530 $6K
87206 1,390 746 $5K
84460 1,469 1,019 $4K
88142 4,504 2,845 $4K
82565 1,297 939 $4K
84550 1,454 954 $3K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 57 53 $3K
82247 1,518 928 $3K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 87 87 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 582 428 $2K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 4,434 4,099 $1K
82948 281 229 $678.13
86701 143 134 $477.36
36415 Collection of venous blood by venipuncture 133 110 $170.28
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 15 12 $117.60
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1,327 712 $0.00